Renal cytochrome P450-derived eicosanoids and hypertension

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

The cytochrome P450 (CYP) monooxygenase system represents a major metabolic pathway of arachidonic acid in the kidney. The primary CYP monooxygenase-derived arachidonic acid metabolites (eicosanoids) in renal tubular and vascular tissues are hydroxyeicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs), which are further metabolized by epoxide hydrolase to dihydroxyeicosatrienoic acids (DHETs). CYP-derived eicosanoids have been shown to affect vascular tone and tubular epithelial transport, contribute to the regulation of renal function, and participate in the long-term control of blood pressure. This review will focus on the biochemistry, pharmacology, and physiological significance of the CYP-derived eicosanoids in the mammalian kidney. In addition, we will also discuss the role of these metabolites in pregnancy- and obesity-induced hypertension in animal models, and in human hypertension.

Original languageEnglish (US)
Pages (from-to)227-236
Number of pages10
JournalCurrent Hypertension Reviews
Volume2
Issue number3
DOIs
StatePublished - Aug 1 2006

Keywords

  • 20-HETE
  • Cytochrome P450
  • DHET
  • EET
  • Eicosanoids
  • Hypertension
  • Kidney
  • Renal function

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Renal cytochrome P450-derived eicosanoids and hypertension'. Together they form a unique fingerprint.

  • Cite this